Literature DB >> 22999380

Contingency management is effective across cocaine-dependent outpatients with different socioeconomic status.

Roberto Secades-Villa1, Gloria García-Fernández, Elsa Peña-Suárez, Olaya García-Rodríguez, Emilio Sánchez-Hervás, José Ramón Fernández-Hermida.   

Abstract

Contingency management (CM) has demonstrated its efficacy for treating cocaine dependence, but there is still some controversy with regard to its dissemination. Understanding how individual differences affect CM outcomes is important for detecting barriers to its dissemination. The aim of this study is to examine the impact of socioeconomic variables in cocaine-dependent outpatients on the effectiveness of CM in a community setting. Cocaine-dependent outpatients (N=118) were randomized to community reinforcement approach (CRA) treatment or a CRA plus vouchers program. The impact of baseline economic variables, alone and in combination with treatment conditions, on abstinence and retention outcomes after 6 months of treatment was assessed. Results showed that income had no effect on retention or abstinence outcomes after 6 months of treatment in either treatment condition. The addition of a CM component was beneficial for individuals with any socioeconomic status. These results support the generalizability of CM strategies with patients of different socioeconomic status in community settings.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 22999380     DOI: 10.1016/j.jsat.2012.08.018

Source DB:  PubMed          Journal:  J Subst Abuse Treat        ISSN: 0740-5472


  17 in total

1.  Contingency Management Abstinence Incentives: Cost and Implications for Treatment Tailoring.

Authors:  Colin Cunningham; Maxine Stitzer; Aimee N C Campbell; Martina Pavlicova; Mei-Chen Hu; Edward V Nunes
Journal:  J Subst Abuse Treat       Date:  2015-09-21

Review 2.  Contingency Management: New Directions and Remaining Challenges for An Evidence-Based Intervention.

Authors:  Carla J Rash; Maxine Stitzer; Jeremiah Weinstock
Journal:  J Subst Abuse Treat       Date:  2016-09-28

3.  Considerations for Implementing Contingency Management in Substance Abuse Treatment Clinics: The Veterans Affairs Initiative as a Model.

Authors:  Carla J Rash; Dominick DePhilippis
Journal:  Perspect Behav Sci       Date:  2019-06-26

4.  Cocaine-using substance abuse treatment patients with and without HIV respond well to contingency management treatment.

Authors:  Ashley E Burch; Carla J Rash; Nancy M Petry
Journal:  J Subst Abuse Treat       Date:  2017-03-09

5.  Sexual orientation and substance use treatment outcomes across five clinical trials of contingency management.

Authors:  Kristyn Zajac; Carla J Rash; Meredith K Ginley; Nicholas C Heck
Journal:  Psychol Addict Behav       Date:  2019-07-25

6.  Impact of Tailored Interventions to Reduce Drug Use and Sexual Risk Behaviors Among Homeless Gay and Bisexual Men.

Authors:  Adeline Nyamathi; Cathy J Reback; Steven Shoptaw; Benissa E Salem; Sheldon Zhang; Kartik Yadav
Journal:  Am J Mens Health       Date:  2016-07-08

7.  Contingency management is effective in promoting abstinence and retention in treatment among crack cocaine users in Brazil: A randomized controlled trial.

Authors:  André Q C Miguel; Clarice S Madruga; Hugo Cogo-Moreira; Rodolfo Yamauchi; Viviane Simões; Claudio J da Silva; Sterling McPherson; John M Roll; Ronaldo R Laranjeira
Journal:  Psychol Addict Behav       Date:  2016-07-21

Review 8.  Psychostimulant addiction treatment.

Authors:  Karran A Phillips; David H Epstein; Kenzie L Preston
Journal:  Neuropharmacology       Date:  2014-04-12       Impact factor: 5.250

Review 9.  Psychosocial interventions for psychostimulant misuse.

Authors:  Silvia Minozzi; Rosella Saulle; Franco De Crescenzo; Laura Amato
Journal:  Cochrane Database Syst Rev       Date:  2016-09-29

10.  Interest and preferences for contingency management design among addiction treatment clientele.

Authors:  Bryan Hartzler; Sharon Garrett
Journal:  Am J Drug Alcohol Abuse       Date:  2015-12-08       Impact factor: 3.829

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.